Kestra Medical Technologies (KMTS) holder to resell 5,936 vested shares

Rhea-AI Filing Summary

Kestra Medical Technologies, Ltd. has a planned resale of common stock by a security holder. The notice covers 5,936 shares of common stock to be sold through Merrill Lynch on or after July 30, 2026 on NASDAQ. These shares relate to the vesting of performance share unit awards on July 17, 2026, which were granted under the issuer’s equity compensation plan.

Key Figures

Shares to be sold: 5,936 shares Aggregate market value: $135,120.73 Planned sale date: 07/30/2026 +2 more

5 metrics

Shares to be sold 5,936 shares Common stock covered by the planned resale

Aggregate market value $135,120.73 Estimated value of the 5,936 common shares to be sold

Planned sale date 07/30/2026 Date listed for NASDAQ sale through Merrill Lynch

Vesting date 07/17/2026 Performance share unit awards vesting date

Security type Common Stock Class of Kestra Medical Technologies shares involved

Key Terms

Form 144, performance share unit awards, equity compensation plan, common stock

4 terms

Form 144 regulatory

"144: Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

performance share unit awards financial

"07/17/2026 | Vesting of performance share unit awards |"

equity compensation plan financial

"Granted as part of issuer equity compensation plan"

A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.

common stock financial

"Common Stock | Merrill Lynch 225 Liberty Street Floor 37"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/30/2026 - 04:34 PM Accepted by SEC EDGAR 07/30/2026 - 04:33 PM Learn about SEC filing dates

FAQ

What does the Form 144-related filing for KMTS disclose?

It discloses a planned resale of 5,936 shares of Kestra Medical Technologies common stock by a security holder through Merrill Lynch on or after July 30, 2026 on NASDAQ.

How many KMTS shares are covered by the planned sale?

The planned transaction covers 5,936 shares of Kestra Medical Technologies common stock. This amount is tied to shares received from the vesting of performance share unit awards under the company’s equity compensation plan.

What is the approximate market value of the KMTS shares to be sold?

The filing lists an aggregate market value of $135,120.73 for the 5,936 common shares planned for resale. This figure reflects the estimated value at the time of the Form 144 notice.

When were the KMTS shares scheduled for sale and on which market?

The shares are scheduled for sale on or after July 30, 2026 on the NASDAQ market. Merrill Lynch is identified as the broker handling the common stock sale.

How were the KMTS shares in this Form 144 obtained?

The 5,936 shares were obtained through the vesting of performance share unit awards on July 17, 2026. These awards were originally granted as part of the issuer’s equity compensation plan.

Does the KMTS Form 144 indicate an equity compensation connection?

Yes. The filing states the shares arise from vesting of performance share unit awards that were granted as part of the issuer equity compensation plan, linking the planned sale to prior compensation awards.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	5936	135120.73	58602497	07/30/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/17/2026	Vesting of performance share unit awards	KESTRA MEDICAL TECHNOLOGIES, LTD.			5936	07/17/2026	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)